Steve Kirsch
Founder, VSRF
Keynote Speaker
In 2020, Steve Kirsch stepped away from a successful career as a Silicon Valley tech engineer to start the Covid-19 Early Treatment Fund (CETF). CETF sponsored clinical trials of existing generic drugs to find a treatment for Covid, and announced its success with the repurposed drug Fluvoxamine on 60 Minutes April 2021. Although Steve and his family received the Covid shots as soon as they were eligible, Steve soon identified alarming safety signals in the Vaccine Adverse Event Reporting System (VAERS). He then founded the Vaccine Safety Research Foundation (VSRF) in August 2021, with a mission to educate the public on the dangers of the shots, bring an end to the Covid vaccination programs, and support the vaccine-injured.In 2020, Steve Kirsch stepped away from a successful career as a Silicon Valley tech engineer to start the Covid-19 Early Treatment Fund (CETF). CETF sponsored clinical trials of existing generic drugs to find a treatment for Covid, and announced its success with the repurposed drug Fluvoxamine on 60 Minutes April 2021. Although Steve and his family received the Covid shots as soon as they were eligible, Steve soon identified alarming safety signals in the Vaccine Adverse Event Reporting System (VAERS). He then founded the Vaccine Safety Research Foundation (VSRF) in August 2021, with a mission to educate the public on the dangers of the shots, bring an end to the Covid vaccination programs, and support the vaccine-injured.
